Skip to content
MedsAcross

Medicine

Potassium citrate 10 mEq tablet

Available on requestPrescription onlyUS FDAGeneric name

Potassium citrate 10 mEq tablet is a generic prescription medicine for oral use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store in a tight container at 20°–25°C (68°–77°F), Excursions permitted…

Key facts

Active ingredient (INN)
Potassium citrate
Brand
Sold under the generic name
Strength
10 mEq
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 30 tablets and 3 more
Manufacturers
Strides PharmaIndiaBryant Ranch PrepackBioComp PharmaUpsher-Smith Laboratories
Origin register
US FDA, United States
Storage
Store in a tight container at 20°–25°C (68°–77°F), Excursions permitted between 15° and 30°C (59° and 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
A12BA02 Potassium citrate
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
1 September 2006
Identifiers
RxCUI 199381, 199376, 898490DailyMed set ID 3dd9c9eb-df19-4ec9-bc77-f3a159b33d94, 2215dc1d-0b5a-469e-9b51-4d7480a51078, 5f38b02c-703c-4fc2-b833-654e41bd617f +3NDC 71335-2871, 0245-0071, 42543-407 +3Application ANDA206813, NDA019071

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet in 1 bottle42543-407-01Strides PharmaIndia1 November 2017
100 tablet in 1 bottle44523-410-01Biocomp Pharma3 December 2024
100 tablet in 1 bottle0245-0071-11Upsher-Smith Laboratories1 September 2006
30 tablet in 1 bottle71335-1706-1Bryant Ranch Prepack10 September 2020
100 tablet in 1 bottle71335-2871-1Bryant Ranch Prepack23 October 2025
100 tablet in 1 bottle72162-2477-1Bryant Ranch Prepack1 May 2025

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 30 August 1985Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Potassium citrate

Clinical summary

Potassium citrate is an anti-coagulant indicated for the management of renal tubular acidosis, among other approved uses. It is available as extended-release tablets and tablets for oral use. MedsAcross supplies Potassium citrate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Potassium citrate

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Potassium citrate 10 mEq tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.